<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Medicine</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B03AE392-7156-485E-A7E0-45F365E092A3"><gtr:id>B03AE392-7156-485E-A7E0-45F365E092A3</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Porter</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FH003371%2F1"><gtr:id>E85A0A7E-404F-4CC8-800B-B150BE0CC1D4</gtr:id><gtr:title>Cell cycle control of DNA double strand break repair and the role of Cdk</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/H003371/1</gtr:grantReference><gtr:abstractText>Our genetic material is subject to damage: double-stranded DNA can become broken in both strands, fracturing chromosomes. Such double-stand breaks (DSBs) must be repaired as accurately as possible; failed or incorrectly controlled repair will lead to scrambling of the genetic material and contribute to the development of genetic disease, including cancer, and to the ageing process. Understanding the repair processes is also important because many biotechnological and therapeutic techniques involve delivering DNA to cells, and the fate of this DNA is determined by the cells' DSB repair machinery. It is proposed here to investigate how the two main cellular mechanisms for repairing DSBs are controlled as cells grow, duplicate and divide. The choice between the two main repair mechanisms (called NHEJ and HRR) is determined by the position of the 'cell cycle': before cells have replicated their genetic material NHEJ predominates, but during and after replication the two pathways coexists, although there is debate over the relative amounts. Regulator proteins that control the timing of DNA replication and division (called cyclin dependent kinases; Cdks) also regulate the choice between HRR and NHEJ. Cdk activity can promote or inhibit HRR at the expense of NHEJ, but is not clear exactly how, when in the cell cycle or which particular type of Cdk does what. We will develop new and improved methods to measure HRR and NHEJ at different stages of the cell cycle, and determine how two particular Cdks, Cdk1 and Cdk2 are involved.</gtr:abstractText><gtr:technicalSummary>DNA double strand breaks (DSBs) occur endogenously or as a result of external agents and repairing them is essential for life. Genetic damage, including unrepaired or incorrectly repaired DSBs, also promotes oncogenesis and underlies biological ageing. Understanding DSB repair pathways is also important because it affects the outcome of therapeutic of biotechnological methods involving delivery of DNA into cells. The two basic DSB repair mechanisms, homologous recombinational repair (HHR) and nonhomologous end-joining (NHEJ) are used differently at different stages of the cell cycle. How and why such variations are controlled is not properly understood. Cyclin dependent kinase (Cdk) activities are now known to influence the choice between HRR and NHEJ and several target proteins involved have been identified. Cdk activity can both promote and impair DSB reapir and it is unclear which Cdks are responsible for these different effects and how they are coordinated effectively. Despite some consensus, different studies do not always agree on how HRR and NHEJ vary during the cell cycle, and technical issues, such as the use of drugs to synchronise the cell cycle, or indirect measurements DSBR, may be partly responsible. It is proposed here to examine individually how Cdk1 and Cdk2 affect DSBR pathways at different stages of the cell cycle. We will use a novel human cell line in which Cdk1 (essential) can be instantaneously and specifically inactivated and Cdk2 (non-essential) optionally depleted by stable RNA interference. We will develop new methods to make DSBs in G1 or in S/G2/M without the use of cell synchronisation, and use novel assays to measure NHEJ and HRR, distinguishing between different forms of these pathways that may be differently regulated. Together these approaches will provide a clearer picture of DSBR during the cell cycle and the role of Cdks.</gtr:technicalSummary><gtr:fund><gtr:end>2013-06-16</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2010-02-22</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>316654</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Humphrey</gtr:description><gtr:id>B41B511D-FA3A-4F60-8B17-237AA83B3C79</gtr:id><gtr:impact>Student gained MSc degree
Publication in Cell Reports</gtr:impact><gtr:outcomeId>545b9893648dc7.68007081-1</gtr:outcomeId><gtr:partnerContribution>Opportunity to be a joint supervisor of a University of Oxford MSc/PhD student</gtr:partnerContribution><gtr:piContribution>Experiemtnal system for looking at DNA damage in human cells</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Invited seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F79CE495-EF82-485E-8364-0049D8BF1959</gtr:id><gtr:impact>Dr Andy Porter was an invited speaker at the Genome Damage and Stability Centre, Sussex University and gave a seminar entitled &amp;quot;Modifying the genome: ends and means&amp;quot;</gtr:impact><gtr:outcomeId>56e069931576e4.48703846</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting Contribition</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F5F3C5BD-D996-4B6F-A6D1-AFED302E98DB</gtr:id><gtr:impact>Attendance and data presentation at British Association for Cancer Research meeting in Oxford University Meeting: &amp;quot;DNA Damage Repair: translation scientific landmarks into new treatments for cancer&amp;quot;

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r_30404671540c279b02</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>poster presentation</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at International Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C776280F-1D11-4C7F-A70C-FA8E4A43F9C8</gtr:id><gtr:impact>Dr Polly Gravells attended and presented a poster at the Keystone Symposium on &amp;quot;Genome Instability and DNA Repair&amp;quot;; in Banff, Canada, March 3-8, 2013.

no notable impacts realised to date</gtr:impact><gtr:outcomeId>r_67948300420cc69298</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>poster presentation</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>To add to the body of knowledge of how the important process of cell proliferation is controlled.

To help career development of staff involved.</gtr:description><gtr:firstYearOfImpact>2010</gtr:firstYearOfImpact><gtr:id>CCF7FD79-21B5-4979-B48A-4742B796E160</gtr:id><gtr:impactTypes><gtr:impactType>Cultural</gtr:impactType></gtr:impactTypes><gtr:outcomeId>545b913081da95.92423319</gtr:outcomeId><gtr:sector>Education,Healthcare,Other</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We generated and characterised human cells in which the activity of a key kinase (CDK1) can be specifically 'tuned' by addition of varying amounts of a drug. We used these cells to investigate how CDK1 controls cell proliferation performing different fuctions at different cell cycle stages, and how it may or may nor be a suitabe target anti-cancer drugs. We found evidence that inhiboroty phosphorylation of CDK1 is not essential for cell proliferation as had been previously thought. We ask developed novel assays for DNA double strand break repair based on endonucleolytic cleavage of the HPRT gene. We intiated studies of how CDK1 inhibition affects these assays.</gtr:description><gtr:exploitationPathways>To further investigate functions of CDK1, e.g. how it controls DNA repair and the role of inhibitory phosphorylation.</gtr:exploitationPathways><gtr:id>201AD954-FBA9-4170-B258-999A3E6809D2</gtr:id><gtr:outcomeId>545b901a8c9462.94960718</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Other</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A number of unique human cell lines that facilitate the analysis of Cdk1 have been generated and made available to the research community</gtr:description><gtr:id>A0946DF3-8A76-459C-8021-A73931C47D03</gtr:id><gtr:impact>Publication in Human Molecular Genetics</gtr:impact><gtr:outcomeId>r-1047553290.6572831c6b2c6dc</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Cell Lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We developed a way to measure various types of DNA double-strand break repair using the endogenous HPRT gene in human cells as a reporter.</gtr:description><gtr:id>1678D2BE-7742-44FE-B352-1E21991C54AE</gtr:id><gtr:impact>This assays formed the basis of air collaboration with Dr Tim Humphrey which has led to further publications and ongoing work.</gtr:impact><gtr:outcomeId>56e06e8c49c351.61013036</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>New ways to measure the repair of DNA damage</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0F11563A-D33A-4808-A76A-F10E026EF557</gtr:id><gtr:title>Use of the HPRT gene to study nuclease-induced DNA double-strand break repair.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4cbed6d00ba01367cf03b1ff7748fe54"><gtr:id>4cbed6d00ba01367cf03b1ff7748fe54</gtr:id><gtr:otherNames>Gravells P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>56e003095804a0.69098677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFC77009-41E3-4450-9768-22990244FAA4</gtr:id><gtr:title>SETD2-dependent histone H3K36 trimethylation is required for homologous recombination repair and genome stability.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76532b54344c18c0287d1f9e3a50d7c9"><gtr:id>76532b54344c18c0287d1f9e3a50d7c9</gtr:id><gtr:otherNames>Pfister SX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5448aab0225a87.10368736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74450943-B866-4717-9573-09B3F2591C6A</gtr:id><gtr:title>Chemical genetic analyses of quantitative changes in Cdk1 activity during the human cell cycle.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4cbed6d00ba01367cf03b1ff7748fe54"><gtr:id>4cbed6d00ba01367cf03b1ff7748fe54</gtr:id><gtr:otherNames>Gravells P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>doi_53d0460468a5d102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78F78C4D-380C-43C8-8119-E28F1EA51271</gtr:id><gtr:title>A role for human homologous recombination factors in suppressing microhomology-mediated end joining.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3444cb2318a42e95d1af1aed72dd53a7"><gtr:id>3444cb2318a42e95d1af1aed72dd53a7</gtr:id><gtr:otherNames>Ahrabi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>585d3e71de4788.56330346</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/H003371/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>